1. Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019
   Koichi Ogura et al, 2024, Japanese Journal of Clinical Oncology CrossRef
2. Calibration and validation of modeled 5-year survival predictions among people with cystic fibrosis treated with the cystic fibrosis transmembrane conductance regulator modulator ivacaftor using United States registry data
   Lisa J. McGarry et al, 2023, PLOS ONE CrossRef
3. Modeling long-term health outcomes of patients with cystic fibrosis homozygous for F508del-CFTR treated with lumacaftor/ivacaftor
   Jaime L. Rubin et al, 2019, Therapeutic Advances in Respiratory Disease CrossRef
4. The survival benefit of radiotherapy in localized primary adult rhabdomyosarcoma
   Ruping Zhao et al, 2020, Asia-Pacific Journal of Clinical Oncology CrossRef
5. Prognostic Factors in Patients with Rhabdomyosarcoma Using Competing-Risks Analysis: A Study of Cases in the SEER Database
   Didi Han et al, 2020, Journal of Oncology CrossRef
6. Statistics of soft-tissue sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan
   Koichi Ogura et al, 2017, Journal of Orthopaedic Science CrossRef
7. Survival nomograms for patients with retroperitoneal soft tissue sarcoma based on the SEER database and an external cohort
   Jing Wu et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
8. Soft tissue sarcoma nomograms and their incorporation into practice
   Dario Callegaro et al, 2017, Cancer CrossRef
9. Is the Number of National Database Research Studies in Musculoskeletal Sarcoma Increasing, and Are These Studies Reliable?
   Joshua M. Lawrenz et al, 2023, Clinical Orthopaedics & Related Research CrossRef
10. Staging Systems and Nomograms for Soft Tissue Sarcoma
    Maria Danieli et al, 2023, Current Oncology CrossRef
11. Prognostic models for RPS patients—Attempting to predict patient outcomes
    Dario Callegaro et al, 2018, Journal of Surgical Oncology CrossRef
12. Rhabdomyosarcoma of the head and neck: impact of demographic and clinicopathologic factors on survival
    Robert J. Lee et al, 2017, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
13. Radioresistance in rhabdomyosarcomas: Much more than a question of dose
    Simona Camero et al, 2022, Frontiers in Oncology CrossRef